Dark Forest Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History

Dark Forest Capital Management’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-5,043	Closed	-$425K	–	1070
2024 Q2	$425K	Sell	5,043 -1,615	-24%	-$129K	0.08%	311
2024 Q1	$487K	Buy	+6,658	New	+$491K	0.08%	289
2023 Q2	–	Sell	-1,949	Closed	-$143K	–	1234
2023 Q1	$143K	Buy	+1,949	New	+$139K	0.03%	536
2021 Q4	–	Sell	-29	Closed	-$3K	–	1627
2021 Q3	$3K	Sell	29 -596	-95%	-$46.1K	﹤0.01%	1147
2021 Q2	$51K	Buy	+625	New	+$52K	0.02%	444

Other funds holding LGND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

SDJVC

St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return

Dark Forest Capital Management's LGND Position: Q3 2024 in Review

Dark Forest Capital Management sold out of Ligand Pharmaceuticals (LGND) in Q3 2024, closing a stake of 5,043 shares — an estimated $425K sold.

Dark Forest Capital Management first reported a position in LGND in Q2 2021 and held it in 5 quarters. The position peaked at $487K in Q1 2024. 243 funds tracked by Wall St. Rank hold LGND as of Q3 2024.

Dark Forest Capital Management reported no remaining Ligand Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
Dark Forest Capital Management sold 5,043 Ligand Pharmaceuticals shares in Q3 2024, an estimated $425K.
Dark Forest Capital Management first reported a position in Ligand Pharmaceuticals in Q2 2021 and held it in 5 quarters.
Dark Forest Capital Management's Ligand Pharmaceuticals position peaked at $487K in Q1 2024.
243 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2024.

Based on Dark Forest Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.